barre, BioNTech, bishara, covid 19 vaccination in the united states, COVID-19 vaccine, group b streptococcal infection, guillainbarre syndrome, haya bishara, health medical pharma, influenza vaccine, Pfizer, rna vaccines, streptococcus agalactiae, sufjan stevens, Tech Industry, Tech News, vaccine
Covid-19 Might Trigger a Rare Paralyzing Condition
New research links the rare neurological condition Guillain-Barré syndrome to covid-19. The study tracked millions of people in Israel, finding that those with a recent history of covid-19 infection were noticeably more likely to develop Guillain-Barré…
